Shareholding disclosure

GEM Global Yield LLC SCS

Declared position

Threshold

Fell below threshold

Timeline

Published

17.09.2026

Transaction

02.06.2025

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

ZA01-000000000SMV2

Beneficial owner

GEM Global Yield LLC SCS

Declared address

GEM GLOBAL YIELD LLC SCS, Luxembourg, LU

Pursuant to a Share Subscription Facility agreement ("SSF") effective April 10, 2023, GEM committed to provide up to CHF 57 million to Kinarus Therapeutics Holding AG in exchange for registered shares of Kinarus Therapeutics Holding AG, par value CHF 0.01 each (the "Shares"), until June 3, 2025, at the discretion of Kinarus Therapeutics Holding AG, subject to certain exceptions and limitations. NO SHARES WERE ISSUED UNDER THIS FACILTY TO KINARUS OR ITS SUCCESSOR COMPANY CURATIS

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

GEM Global Yield LLC SCS

Curatis Holding AG17.09.2026ZA01-000000000SMV2

Disclosure summary

GEM Global Yield LLC SCS disclosed a holding in Curatis Holding AG that fell below the publication threshold, published by SIX Exchange Regulation on 17.09.2026, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

GEM Global Yield LLC SCS disclosed a holding in Curatis Holding AG, published on 17.09.2026.

Publication date17.09.2026

Transaction date02.06.2025

Issuing companyCuratis Holding AG

Beneficial ownerGEM Global Yield LLC SCS

Declared addressGEM GLOBAL YIELD LLC SCS, Luxembourg, LU

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDZA01-000000000SMV2

Conditions

Pursuant to a Share Subscription Facility agreement ("SSF") effective April 10, 2023, GEM committed to provide up to CHF 57 million to Kinarus Therapeutics Holding AG in exchange for registered shares of Kinarus Therapeutics Holding AG, par value CHF 0.01 each (the "Shares"), until June 3, 2025, at the discretion of Kinarus Therapeutics Holding AG, subject to certain exceptions and limitations. NO SHARES WERE ISSUED UNDER THIS FACILTY TO KINARUS OR ITS SUCCESSOR COMPANY CURATIS

Source: SIX Exchange Regulation · Publication date: 17.09.2026

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open